Overview
- The Food and Drug Administration suspended Zepto’s Dharavi warehouse licence on June 1 after inspectors uncovered fungal contamination, expired products and unsanitary storage conditions
- Zepto appealed the suspension and on June 13 the state food safety agency conducted a detailed reinspection, reviewing the company’s audit, water tests and photographic evidence
- An appellate authority revoked the suspension following Zepto’s submission of a compliance report demonstrating corrective measures to meet regulatory standards
- The warehouse operated by licensee Drogheria Sellers under Zepto’s B2B model resumed order fulfilment on June 14
- Observers warn that thin margins and commission fees for warehouse partners can constrain maintenance spending, prompting heightened regulatory scrutiny of quick commerce operations